Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Market Cap	26.53B
Revenue (ttm)	13.93B
Net Income (ttm)	2.20B
Shares Out	4.57B
EPS (ttm)	0.48
PE Ratio	12.13
Forward PE	10.97
Dividend	0.23 (3.94%)
Ex-Dividend Date	Jun 2, 2025

Volume	9,976,207
Average Volume	13,997,272
Open	5.43
Previous Close	5.81
Day's Range	5.43 - 5.86
52-Week Range	3.60 - 6.54
Beta	0.59
RSI	57.78
Earnings Date	Mar 27, 2025

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 12,719
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2024, HKG:1066's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY